GE HealthCare Technologies prices $1.25 billion in new notes offering

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced Monday that it has commenced and priced an underwritten public offering totaling $1.25 billion in senior notes, according to a statement filed with the Securities and Exchange Commission. The healthcare equipment company, with a current market capitalization of $36.6 billion, is adding to its existing total debt of $10.7 billion as of the most recent quarter.

The offering consists of $600 million aggregate principal amount of 4.150% notes due December 15, 2028, and $650 million aggregate principal amount of 4.950% notes due December 15, 2035. The notes are expected to be issued on or around December 15, 2025, subject to customary closing conditions. Despite the new debt issuance, InvestingPro data shows the company maintains a reasonable debt-to-equity ratio of 1.08 and an Altman Z-Score of 2.66, indicating moderate financial stability.

The company entered into an underwriting agreement on Monday with Goldman Sachs & Co. LLC and BNP Paribas Securities Corp., acting as representatives of the underwriters.

The offering is being made pursuant to a shelf registration statement on Form S-3, filed with the SEC on June 28, 2024.

GE HealthCare Technologies is incorporated in Delaware and is headquartered in Chicago, Illinois. Its common stock is listed on the Nasdaq Stock Market under the ticker symbol GEHC.

This information is based on a press release statement included in the company’s SEC filing.

In other recent news, GE HealthCare announced a quarterly cash dividend of $0.035 per share, payable on February 13, 2026, to shareholders of record as of January 9, 2026. The company has also submitted a 510(k) application to the U.S. Food and Drug Administration for its Photonova Spectra, a photon counting computed tomography system featuring Deep Silicon detector technology. At the Radiological Society of North America Annual Meeting, GE HealthCare showcased new imaging technologies powered by NVIDIA, including the Photonova Spectra, SIGNA Sprint with Freelium MRI, and Vivid Pioneer cardiovascular ultrasound system. Additionally, GE HealthCare introduced the Allia Moveo, a cable-free interventional imaging system designed to enhance mobility and flexibility in medical procedures. The company also unveiled its Genesis Radiology Workspace, aimed at optimizing radiology workflows and enabling remote work for radiologists, with its Genesis View diagnostic viewer pending FDA clearance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.